X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1665) 1665
Book Review (440) 440
Publication (120) 120
Book Chapter (16) 16
Newsletter (9) 9
Conference Proceeding (3) 3
Book / eBook (1) 1
Magazine Article (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1552) 1552
humans (1506) 1506
ticlopidine - analogs & derivatives (1412) 1412
clopidogrel (930) 930
male (808) 808
ticlopidine - therapeutic use (715) 715
female (675) 675
platelet aggregation inhibitors - therapeutic use (657) 657
middle aged (560) 560
ticlopidine - pharmacokinetics (524) 524
aged (483) 483
platelet aggregation inhibitors - pharmacokinetics (464) 464
pharmacology & pharmacy (463) 463
aspirin (460) 460
ticlopidine - administration & dosage (452) 452
ticlopidine - pharmacology (434) 434
percutaneous coronary intervention (393) 393
platelet aggregation inhibitors - pharmacology (392) 392
ticlopidine - adverse effects (378) 378
platelet aggregation inhibitors - administration & dosage (377) 377
cardiac & cardiovascular systems (375) 375
platelet aggregation - drug effects (374) 374
platelet aggregation inhibitors - adverse effects (364) 364
treatment outcome (359) 359
drug interactions (310) 310
pharmacokinetics (299) 299
abridged index medicus (268) 268
acute coronary syndromes (267) 267
antiplatelet therapy (264) 264
adult (261) 261
aspirin - therapeutic use (259) 259
prasugrel (252) 252
peripheral vascular disease (241) 241
drug therapy, combination (238) 238
hematology (232) 232
genotype (230) 230
risk factors (226) 226
ticlopidine (223) 223
cytochrome p-450 cyp2c19 (222) 222
myocardial-infarction (207) 207
blood platelets - drug effects (206) 206
aryl hydrocarbon hydroxylases - genetics (204) 204
drug therapy (199) 199
platelet reactivity (190) 190
animals (184) 184
coronary heart disease (183) 183
acute coronary syndrome - drug therapy (177) 177
thrombosis (176) 176
prasugrel hydrochloride (174) 174
stents (170) 170
cardiology (163) 163
blood platelets (162) 162
inhibition (159) 159
platelet function tests (154) 154
adenosine - analogs & derivatives (152) 152
cardiac patients (152) 152
polymorphism, genetic (151) 151
therapy (150) 150
cyp2c19 (149) 149
cytochrome p-450 (147) 147
dose-response relationship, drug (147) 147
active metabolite (139) 139
drug resistance (136) 136
prospective studies (135) 135
cardiovascular (134) 134
aspirin - administration & dosage (133) 133
pharmacogenetics (133) 133
proton pump inhibitors (132) 132
stent thrombosis (132) 132
aggregation (131) 131
analysis (131) 131
risk (131) 131
heart attacks (130) 130
medicine & public health (130) 130
acute coronary syndrome (128) 128
time factors (125) 125
care and treatment (123) 123
metabolites (123) 123
ticagrelor (123) 123
cardiovascular diseases (122) 122
cardiovascular events (121) 121
of-function polymorphism (119) 119
cardiovascular disease (118) 118
coronary artery disease - drug therapy (117) 117
pharmacodynamics (116) 116
artery-disease (115) 115
research (114) 114
ticlopidine - blood (111) 111
ticlopidine - metabolism (111) 111
trial (110) 110
administration, oral (109) 109
resistance (109) 109
medicine, general & internal (108) 108
acute myocardial-infarction (107) 107
cytochrome p-450 cyp2c19 - genetics (107) 107
platelets (107) 107
dosage and administration (106) 106
purinergic p2y receptor antagonists - therapeutic use (105) 105
stroke (101) 101
cross-over studies (100) 100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1616) 1616
German (20) 20
Russian (16) 16
Spanish (8) 8
French (6) 6
Chinese (4) 4
Dutch (2) 2
Japanese (2) 2
Korean (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 8, pp. 872 - 879
Objectives This study sought to determine whether known genetic, drug, dietary, compliance, and lifestyle factors affecting clopidogrel absorption and... 
Cardiovascular | Internal Medicine | pharmacokinetics | risk factors | receptors | drugs | platelets | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | GENOTYPE | REACTIVITY | TRIAL | CIGARETTE-SMOKING | PARAOXONASE-1 | RESISTANCE | PRASUGREL | ABSORPTION | ASSOCIATION | Area Under Curve | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Drug Monitoring - methods | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - blood | Ticlopidine - administration & dosage | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Drug Therapy, Combination | Platelet Aggregation - genetics | Cardiovascular Diseases - etiology | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics | Platelet Function Tests - methods | Aryldialkylphosphatase - genetics | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Cross-Over Studies | Smoking - metabolism | Confounding Factors (Epidemiology) | Proton Pump Inhibitors - pharmacokinetics | Blood Coagulation - drug effects | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Cardiovascular Diseases - psychology | Patient Compliance | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Phosphates | Drugs | Prescribing | Medical colleges | Continuing medical education | Metabolites | Vasodilators | Cytochrome P-450 | Physiological aspects | Proton pump inhibitors | Genetic aspects | Patient compliance | Research institutes | Studies | Cytochrome | Body mass index | Nutrition research | Genotype & phenotype | Demographics | Drug therapy | Acute coronary syndromes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2013, Volume 62, Issue 6, pp. 505 - 512
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Four randomized, placebo‐controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between... 
VARIABILITY | LANSOPRAZOLE | RABEPRAZOLE | THERAPY | CARDIOVASCULAR EVENTS | STENT PLACEMENT | PHARMACOLOGY & PHARMACY | OUTCOMES | ANTIPLATELET ACTION | PROTON-PUMP INHIBITORS | DRUG-INTERACTION | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Ticlopidine - analogs & derivatives | Cross-Over Studies | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Platelet Activation - drug effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Prodrugs - pharmacology | Ticlopidine - blood | Omeprazole | Pantoprazole | Drug interactions | Analysis | Dosage and administration | Research | Patients | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 04/2008, Volume 48, Issue 4, pp. 475 - 484
Journal Article
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 08/2004, Volume 92, Issue 2, pp. 311 - 316
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 10/2011, Volume 4, Issue 5, pp. 422 - 428
BACKGROUND—Reduced concentrations of clopidogrel active metabolite have been associated with diminished platelet inhibition and higher rates of adverse... 
Myocardial infarction | Coronary stenting | Paraoxonase-1 | Cytochrome P450 | Clopidogrel | Pharmacokinetics | Platelets | Coronary artery disease | Genetic polymorphisms | clopidogrel | coronary artery disease | RESPONSE VARIABILITY | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | myocardial infarction | cytochrome P450 | genetic polymorphisms | platelets | DIABETES-MELLITUS | paraoxonase-1 | POLYMORPHISMS | SERUM PARAOXONASE | coronary stenting | pharmacokinetics | ASSOCIATION | CARDIOVASCULAR RISK | PLATELET REACTIVITY | ACTIVE METABOLITE | Myocardial Infarction - genetics | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Male | Platelet Aggregation Inhibitors - blood | DNA Mutational Analysis | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Adult | Female | Myocardial Infarction - physiopathology | Platelet Aggregation Inhibitors - adverse effects | Risk Factors | Genotype | Treatment Outcome | Mutation - genetics | Aryldialkylphosphatase - genetics | Aryldialkylphosphatase - metabolism | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Polymorphism, Genetic | Cross-Over Studies | Myocardial Infarction - drug therapy | Cytochrome P-450 CYP2C19 | Survival Analysis | Biomarkers, Pharmacological - metabolism | Cohort Studies | Ticlopidine - blood | Index Medicus
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 07/2010, Volume 70, Issue 1, pp. 65 - 77
Journal Article